In the Original Investigation titled “Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality,”1 the labels in the key of Figure 2 were reversed. The orange line indicates “5-ARI,” and the blue line, “No 5-ARI.” Erroneous percentages were also removed from the Results section. This article was corrected online.
References
- 1.Björnebo L, Nordström T, Discacciati A, et al. Association of 5α-reductase inhibitors with prostate cancer mortality. JAMA Oncol. 2022;8(7):1019-1026. doi: 10.1001/jamaoncol.2022.1501 [DOI] [PMC free article] [PubMed] [Google Scholar]